Jaylynn Kao, MD in Eugene, OR - Pediatrics

Jaylynn Kao, MD is a Pediatrics physician based in Eugene, Oregon. Jaylynn Kao is licensed to practice in Oregon (license number MD27227) and her current practice location is 1580 Valley River Dr, Suite 210, Eugene, Oregon. She can be reached at her office (for appointments etc.) via phone at (541) 687-4900.

NPI number for Jaylynn Kao is 1346221439 and her current mailing address is Po Box 1648, Eugene, Oregon. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1346221439.

Contact Information

	Jaylynn Kao, MD
	1580 Valley River Dr, Suite 210, Eugene, OR 97401-2116
	(541) 687-4900
	(541) 687-4904

Physician's Profile

Full Name	Jaylynn Kao
Gender	Female
Speciality	Pediatrics
Location	1580 Valley River Dr, Eugene, Oregon
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1346221439
Provider Enumeration Date: 11/07/2005
Last Update Date: 10/26/2011

Medical Identifiers

Medical identifiers for Jaylynn Kao such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1346221439	NPI	-	NPPES
272371	Medicaid	OR

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	MD27227 (Oregon)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jaylynn Kao is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jaylynn Kao, MD Po Box 1648, Eugene, OR 97440-1648 Ph: (541) 687-4900	Jaylynn Kao, MD 1580 Valley River Dr, Suite 210, Eugene, OR 97401-2116 Ph: (541) 687-4900

News Archive

Tioga commences dosing in Phase 3 trial of asimadoline for diarrhea-predominant irritable bowel syndrome

Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.

Research: 2 forms of iron to treat cystic fibrosis lung infection

The bacterium Pseudomonas aeruginosa needs iron to establish and maintain a biofilm in the lungs of cystic fibrosis patients, and therapies have been proposed to deprive the bacteria of this necessary element.

EAU publishes live webcasts of sessions from 25th Anniversary EAU Congress

The Anniversary EAU Congress started successfully yesterday, although the force majeure circumstances - the eruption of a volcano in Iceland - which shut down many North-European airports, made changes in the programme necessary. To accomodate all urologists, health professionals, media representatives etc who have been stranded due to the volcanic eruption in Iceland, the EAU is publishing live webcasts of the sessions from the 25th Anniversary EAU Congress.

Health IT news: Grassley queries hospitals, Microsoft's CEO sees need to boost tech for doctors, hospitals

Modern Healthcare: "Sen. Chuck Grassley (R-Iowa) has sent a letter asking 31 hospitals to report on their relationships with healthcare IT vendors, focusing on errors caused by IT systems and on so-called 'gag order or non-disclosure clauses' in vendor contracts that might prohibit the hospitals from disclosing information about system flaws." Grassley made a similar request to the IT vendors themselves last fall, and said his new letter was prompted by concern about taxpayers' investment in health IT as part of the economic stimulus (Conn, 1/20).

Researchers map malaria parasite P vivax; Nearly 3B people at risk of infection in 2009

A new evidence-based map estimates that in 2009 2.85 billion people lived "at risk of infection" with the malaria parasite Plasmodium vivax, BMJ News reports. As described in a study, published Tuesday in PLoS Neglected Tropical Diseases, P vivax "is more widespread and potentially represents a greater burden on human health in some parts of the world than P falciparum, the species usually associated with the greatest mortality and morbidity," BMJ News writes (Moszynski, 8/3).

Pediatrics Doctors in Eugene, OR

Bruce S Strimling, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4135 Quest Dr, Eugene, OR 97402 Phone: 541-461-8006 Fax: 541-463-2197
Dr. Nicole Maria-phyllis Hauck, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 151 W 7th Ave, Suite 100, Eugene, OR 97401 Phone: 541-682-3550
Dr. William David Lux, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1200 Hilyard St, Suite 440, Eugene, OR 97401 Phone: 541-687-9061 Fax: 541-687-6067
David Scott Miller, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 995 Willagillespie Rd, Ste 200, Eugene, OR 97401 Phone: 541-341-3717 Fax: 541-302-8107
Karen Weiner, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1650 Chambers St, Eugene, OR 97402 Phone: 541-338-7787 Fax: 541-684-3077
Larry George Fickenscher, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: University Of Oregon Student Health Center, 1590 East 13th Avenue, Eugene, OR 97403 Phone: 541-346-4447 Fax: 541-346-2747
Dr. Kevin P. Marks, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4010 Aerial Way, Eugene, OR 97402 Phone: 541-242-8500 Fax: 541-242-8491

Jaylynn Kao, MD - Pediatrics in Eugene, OR